Literature DB >> 34866048

Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic.

Nina Talmor, Abhinay Ramachandran, Shari B Brosnahan, Binita Shah, Sripal Bangalore, Louai Razzouk, Michael Attubato, Frederick Feit, Craig Thompson, Nathaniel R Smilowitz1.   

Abstract

BACKGROUND: The initial wave of the coronavirus disease 2019 (COVID-19) pandemic resulted in an influx of patients with acute viral illness and profound changes in healthcare delivery in New York City. The impact of this pandemic on the presentation and invasive management of acute myocardial infarction (MI) is not well described.
METHODS: This single-center retrospective study compared patients with MI who underwent invasive coronary angiography at New York University from March-April 2020, during the peak of the first wave of the pandemic, with those presenting in March-April 2019.
RESULTS: Only 35 patients with MI underwent angiography during the study period in 2020 vs 109 patients in 2019. No differences in comorbidities or baseline medications were identified. The proportion of patients with ST-segment elevation MI (STEMI) was higher in 2020 than in 2019 (48.6% vs 24.8%, respectively; P=.01). Median peak troponin concentration was higher (14.5 ng/mL vs 2.9 ng/mL; P<.01) and left ventricular ejection fraction was lower (43.34% vs 51.1%; P=.02) during the pandemic. Among patients with non-STEMI, time from symptom onset to presentation was delayed in 2020 compared with 2019 (median, 24 hours vs 10 hours; P=.04).
CONCLUSION: There was a dramatic decrease in the number of patients with MI undergoing coronary angiography during the first wave of the COVID-19 pandemic. Of those who presented, patients tended to seek care later after symptom onset and had excess myocardial injury. These data indicate a need for improved patient education to ensure timely cardiovascular care during public health emergencies.

Entities:  

Keywords:  COVID-19; ST-segment elevation myocardial infarction; coronavirus disease 2019

Mesh:

Year:  2021        PMID: 34866048      PMCID: PMC8904201     

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  26 in total

1.  Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis.

Authors:  Jia-Fu Wei; Fang-Yang Huang; Tian-Yuan Xiong; Qi Liu; Hong Chen; Hui Wang; He Huang; Yi-Chun Luo; Xuan Zhou; Zhi-Yue Liu; Yong Peng; Yuan-Ning Xu; Bo Wang; Ying-Ying Yang; Zong-An Liang; Xue-Zhong Lei; Yang Ge; Ming Yang; Ling Zhang; Ming-Quan Zeng; He Yu; Kai Liu; Yu-Heng Jia; Bernard D Prendergast; Wei-Min Li; Mao Chen
Journal:  Heart       Date:  2020-04-30       Impact factor: 5.994

2.  Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic.

Authors:  Ankeet S Bhatt; Alea Moscone; Erin E McElrath; Anubodh S Varshney; Brian L Claggett; Deepak L Bhatt; James L Januzzi; Javed Butler; Dale S Adler; Scott D Solomon; Muthiah Vaduganathan
Journal:  J Am Coll Cardiol       Date:  2020-05-26       Impact factor: 24.094

3.  Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.

Authors:  Christopher M Petrilli; Simon A Jones; Jie Yang; Harish Rajagopalan; Luke O'Donnell; Yelena Chernyak; Katie A Tobin; Robert J Cerfolio; Fritz Francois; Leora I Horwitz
Journal:  BMJ       Date:  2020-05-22

4.  Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series.

Authors:  Amy V Rapkiewicz; Xingchen Mai; Steven E Carsons; Stefania Pittaluga; David E Kleiner; Jeffrey S Berger; Sarun Thomas; Nicole M Adler; David M Charytan; Billel Gasmi; Judith S Hochman; Harmony R Reynolds
Journal:  EClinicalMedicine       Date:  2020-06-25

5.  Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes.

Authors:  Denis Doyen; Pamela Moceri; Dorothée Ducreux; Jean Dellamonica
Journal:  Lancet       Date:  2020-04-23       Impact factor: 79.321

6.  Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic.

Authors:  Santiago Garcia; Mazen S Albaghdadi; Perwaiz M Meraj; Christian Schmidt; Ross Garberich; Farouc A Jaffer; Simon Dixon; Jeffrey J Rade; Mark Tannenbaum; Jenny Chambers; Paul P Huang; Timothy D Henry
Journal:  J Am Coll Cardiol       Date:  2020-04-10       Impact factor: 24.094

7.  Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage.

Authors:  Bernhard Metzler; Peter Siostrzonek; Ronald K Binder; Axel Bauer; Sebastian Johannes Reinstadler
Journal:  Eur Heart J       Date:  2020-05-14       Impact factor: 29.983

8.  Myocardial Injury in Adults Hospitalized With COVID-19.

Authors:  Nathaniel R Smilowitz; Neil Jethani; Ji Chen; Yindalon Aphinyanaphongs; Ruina Zhang; Siddhant Dogra; Carlos L Alviar; Norma Keller; Louai Razzouk; Adriana Quinones-Camacho; Albert S Jung; Glenn I Fishman; Judith S Hochman; Jeffrey S Berger
Journal:  Circulation       Date:  2020-11-05       Impact factor: 29.690

9.  Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: An insight from a meta-analysis.

Authors:  Tadao Aikawa; Hisato Takagi; Kiyotake Ishikawa; Toshiki Kuno
Journal:  J Med Virol       Date:  2020-06-19       Impact factor: 20.693

10.  Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States.

Authors:  Santiago Garcia; Larissa Stanberry; Christian Schmidt; Scott Sharkey; Michael Megaly; Mazen S Albaghdadi; Perwaiz M Meraj; Ross Garberich; Farouc A Jaffer; Ada C Stefanescu Schmidt; Simon R Dixon; Jeffrey J Rade; Timothy Smith; Mark Tannenbaum; Jenny Chambers; Frank Aguirre; Paul P Huang; Dharam J Kumbhani; Thomas Koshy; Dmitriy N Feldman; Jay Giri; Prashant Kaul; Craig Thompson; Houman Khalili; Brij Maini; Keshav R Nayak; Mauricio G Cohen; Sripal Bangalore; Binita Shah; Timothy D Henry
Journal:  Catheter Cardiovasc Interv       Date:  2020-08-07       Impact factor: 2.585

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.